AR230266A1 - Procedimiento para obtener haluros de 2-(2-(2-(4metoxibenzoil)amino)-fenil)-etil)-1,1-metilalquil o bencilpiperidinio - Google Patents

Procedimiento para obtener haluros de 2-(2-(2-(4metoxibenzoil)amino)-fenil)-etil)-1,1-metilalquil o bencilpiperidinio

Info

Publication number
AR230266A1
AR230266A1 AR288281A AR28828182A AR230266A1 AR 230266 A1 AR230266 A1 AR 230266A1 AR 288281 A AR288281 A AR 288281A AR 28828182 A AR28828182 A AR 28828182A AR 230266 A1 AR230266 A1 AR 230266A1
Authority
AR
Argentina
Prior art keywords
benzylpiperidinum
methylalkyl
phenyl
ethyl
amino
Prior art date
Application number
AR288281A
Other languages
English (en)
Spanish (es)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of AR230266A1 publication Critical patent/AR230266A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AR288281A 1981-01-28 1982-01-28 Procedimiento para obtener haluros de 2-(2-(2-(4metoxibenzoil)amino)-fenil)-etil)-1,1-metilalquil o bencilpiperidinio AR230266A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/229,244 US4321386A (en) 1981-01-28 1981-01-28 Quaternary piperidinium halides

Publications (1)

Publication Number Publication Date
AR230266A1 true AR230266A1 (es) 1984-03-01

Family

ID=22860396

Family Applications (1)

Application Number Title Priority Date Filing Date
AR288281A AR230266A1 (es) 1981-01-28 1982-01-28 Procedimiento para obtener haluros de 2-(2-(2-(4metoxibenzoil)amino)-fenil)-etil)-1,1-metilalquil o bencilpiperidinio

Country Status (19)

Country Link
US (1) US4321386A (cg-RX-API-DMAC7.html)
JP (1) JPH0348904B2 (cg-RX-API-DMAC7.html)
AR (1) AR230266A1 (cg-RX-API-DMAC7.html)
AT (1) AT378183B (cg-RX-API-DMAC7.html)
AU (1) AU551523B2 (cg-RX-API-DMAC7.html)
BE (1) BE891938A (cg-RX-API-DMAC7.html)
CA (1) CA1184917A (cg-RX-API-DMAC7.html)
CH (1) CH651021A5 (cg-RX-API-DMAC7.html)
DE (1) DE3223499T1 (cg-RX-API-DMAC7.html)
DK (1) DK156649C (cg-RX-API-DMAC7.html)
FI (1) FI65239C (cg-RX-API-DMAC7.html)
GB (1) GB2100736B (cg-RX-API-DMAC7.html)
GR (1) GR74720B (cg-RX-API-DMAC7.html)
IE (1) IE52420B1 (cg-RX-API-DMAC7.html)
IT (1) IT1147809B (cg-RX-API-DMAC7.html)
NL (1) NL8220049A (cg-RX-API-DMAC7.html)
SE (1) SE435057B (cg-RX-API-DMAC7.html)
WO (1) WO1982002551A1 (cg-RX-API-DMAC7.html)
YU (1) YU43063B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG176772A1 (en) * 2009-04-09 2012-01-30 Cognition Therapeutics Inc Inhibitors of cognitive decline
EP2458983B1 (en) 2009-07-31 2015-07-08 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
RU2013140467A (ru) 2011-02-02 2015-03-10 Когнишн Терапьютикс, Инк. Выделенные соединения из масла куркумы и способы применения
KR102331422B1 (ko) 2014-01-31 2021-11-25 카그니션 테라퓨틱스, 인코퍼레이티드 아이소인돌린 조성물 및 신경퇴행성 질환을 치료하는 방법
US11214540B2 (en) 2017-05-15 2022-01-04 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3037910A (en) * 1958-04-18 1962-06-05 Burroughs Wellcome Co Process for treatment of hypertension
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
US3917679A (en) * 1974-04-12 1975-11-04 Lilly Co Eli Quaternary ammonium salts of N-dialkylaminoalkyl-N-(2-indanyl)anilines

Also Published As

Publication number Publication date
CA1184917A (en) 1985-04-02
IT1147809B (it) 1986-11-26
DE3223499T1 (de) 1983-01-13
SE8205535L (sv) 1982-09-28
DK156649B (da) 1989-09-18
AU8148582A (en) 1982-08-16
JPS57502216A (cg-RX-API-DMAC7.html) 1982-12-16
ATA900782A (de) 1984-11-15
FI822443A0 (fi) 1982-07-08
FI822443L (fi) 1982-07-08
SE8205535D0 (sv) 1982-09-28
GB2100736A (en) 1983-01-06
CH651021A5 (de) 1985-08-30
IT8247667A0 (it) 1982-01-28
YU43063B (en) 1989-02-28
JPH0348904B2 (cg-RX-API-DMAC7.html) 1991-07-25
IE820191L (en) 1982-07-28
AT378183B (de) 1985-06-25
SE435057B (sv) 1984-09-03
DK429382A (da) 1982-09-27
FI65239C (fi) 1984-04-10
US4321386A (en) 1982-03-23
GB2100736B (en) 1985-01-30
BE891938A (fr) 1982-07-28
GR74720B (cg-RX-API-DMAC7.html) 1984-07-10
DK156649C (da) 1990-02-05
NL8220049A (nl) 1982-11-01
WO1982002551A1 (en) 1982-08-05
DE3223499C2 (cg-RX-API-DMAC7.html) 1989-11-23
FI65239B (fi) 1983-12-30
IE52420B1 (en) 1987-10-28
AU551523B2 (en) 1986-05-01
YU19782A (en) 1985-04-30

Similar Documents

Publication Publication Date Title
ES535945A0 (es) Procedimiento para preparar 2-(bezoil-2-sustituido)-ciclohexano-1, 3-dionas herbicidas
ES535946A0 (es) Procedimiento para preparar 2-(2-benzoil sustituido)-1, 3-ciclohexanodionas
ES516275A0 (es) Procedimiento para preparar 1,2-dihidroxi-ciclohexadienos.
ES523733A0 (es) Procedimiento para preparar acilanilidas.
ES523067A0 (es) Procedimiento para preparar 1-(2-(fenilmetilen)ciclohexil) azetidinas.
ES515786A0 (es) Procedimiento para preparar metilaminas.
ES537343A0 (es) Procedimiento para la obtencion de azoles 2, 4, 5-trisustituidos
AR230266A1 (es) Procedimiento para obtener haluros de 2-(2-(2-(4metoxibenzoil)amino)-fenil)-etil)-1,1-metilalquil o bencilpiperidinio
MX6975E (es) Procedimiento para preparar s,s-dialquil-fosforoditioatos de o-alquilo
ES522324A0 (es) Procedimiento para la obtencion de 2-(4-hidroxifenoxi)-propionatos.
ES527279A0 (es) Un procedimiento para obtener 2-(2,3,5-tri-o-aril-b-d-ribofuranosil)selenazol-4-carboxilatos de alcohilo o aralcohilo
ES508729A0 (es) Procedimiento para preparar amidas.
ES510302A0 (es) Procedimiento para la preparacion de 4-(3-trifluormetilfenil)-1,2,3,6-tetrahidropiridinas.
AR229877A1 (es) Procedimiento para preparar 1-(2-(4,5,10,11-tetrahidro-1-h-dibenzo(a,d)ciclohepten-5-il)-etil)pirro-lidina
ES518680A0 (es) Procedimiento para preparar compuestos de ferrosiloxano.
ES514364A0 (es) Procedimiento para preparar 2-cianoesteroides.
ES534092A0 (es) Procedimiento para la obtencion de 2-(n-(2-hidroxietil)-carbamoil)-3-metil-quinoxalin-1, 4-n-dioxido estabilizado
ES544205A0 (es) Procedimiento para preparar 2- (fenetil) -5- (3,4-metilen- dioxi)-x-hidroxibencil) -pirrolidina
ES517996A0 (es) Un procedimiento para preparacion de 2-(2-piridila cetil)-p-anisanilida.
ES516922A0 (es) Procedimiento para la obtencion de o-pirazol-4-il-carbamatos n-sustituidos.
ES512595A0 (es) Procedimiento para preparar 4-alquil-tiofenil-etanolaminas.
ES511768A0 (es) Procedimiento para la obtencion de i-alquenos.
ES512511A0 (es) Procedimiento para preparar 4-(2-aminoetiltiometil)-5-metilimidazol.
ES511967A0 (es) Procedimiento para la obtencion de sulfenamidas.
ES511969A0 (es) Procedimiento para la obtencion de 2-aminoetanoles sustituidos.